Biotech Law 
Myrexis Appoints New Executive Management Team in Alignment With Strategic Initiatives – msnbc.com
Mr. Brewer is the former Chief Executive Officer of Scios, Inc. and has served as Chairman of several biotechnology companies … no duty to update this information unless required by law. The Myrexis, Inc. logo is available at http …
Strategy and tactics of disarming GHG at the source: N2O reductase crops
Shen Wan, Tonya Lynn Ward, Illimar Altosaar. Nitrous oxide (N2O), the third most abundant greenhouse gas (GHG), is highly stable and plays a significant role in stratospheric ozone destruction. The primary anthropogenic source of ….
Covance foes cheer departure of biotech company – AZCentral.com
It doesn’t identify its clients other than to say it contracts with pharmaceutical companies, food companies and small biotech firms to test products … did not violate the state’s Open Meeting Law. Most of the construction was finished in …
Amakem Appoints Dr. Steve Pakola as Chief Medical Officer; Dr. George Lasezkay Joins Board of Directors – Yahoo Finance
Both have exceptional track records in the biotechnology industry and bring a wealth of … at Buffalo and a J.D. degree from the University of Southern California Law Center. He also holds a certificate in alternative dispute resolution from …
Onetime "King of Biotech" runs afoul of law again – Chicago Tribune
NEW YORK (Reuters) – David Blech, an investor who was known as the “King of Biotech” before he admitted to criminal charges of stock manipulation in 1998, has run into trouble with the law again over illegal trades in stocks … Continue reading
Harvard grad sues to revoke plagiarism finding – Law.com
Hamburger declined to comment when reached on May 11. Walker enrolled at Harvard Law School in 2006 after completing a bachelors of science degree in biotechnology from the Rochester Institute of Technology at age 19. She followed up with a … Continue reading
Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars – Yahoo Finance
On March 23, 2010, President Barack Obama signed into law the Patient Protection and Affordable … manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize …
Onetime "King of Biotech" runs afoul of law again – in.news.yahoo.com
NEW YORK (Reuters) – David Blech, an investor who was known as the “King of Biotech” before he admitted to criminal charges of stock manipulation in 1998, has run into trouble with the law again over illegal trades in stocks … Continue reading
SEC Hits Biotech Investor With Market Manipulation Suit – site.law360.com
Law360, New York (May 10, 2012, 7:00 PM ET) — Biotechnology financier David Blech, who pled guilty Wednesday to securities fraud for manipulating the stock prices of two biotech companies, will now have to face off with the U.S. Securities … Continue reading
Onetime "King of Biotech" runs afoul of law again – Town Hall
NEW YORK (Reuters) – David Blech, an investor who was known as the “King of Biotech” before he admitted to criminal charges of stock manipulation in 1998, has run into trouble with the law again over illegal trades in stocks … Continue reading
